IPune, Maharashtra, Okthobha 22 2020 (Wiredrelease) Imizobo yoPhando-: Ukunyuka okungaguqukiyo kwenani lamatyala e-COVID-19 kukhokelele kwimfuno eyomeleleyo yezisombululo zokufumanisa intsholongwane. Iikiti ze-COVID-19 zokuchonga zisetyenziselwa ukuhlalutya kunye nokufumanisa ubukho bentsholongwane ye-SARS-CoV-2 kumntu onokuthi aphathe usulelo.
Kwingingqi yeAsia Pacific apho ama-60% abemi behlabathi bahlala kwiindawo ezinabantu abaninzi, umngcipheko we-COVID-19 uyanda ngokuthe chu ngaphandle kwemizamo yokuthintela. Ukunyuka okuxhaphakileyo kwe-coronavirus kuye kwanefuthe kumazwe amaninzi aseAsia Pacific ukuba athathe amanyathelo angqongqo kwaye anyuse umgangatho wokuvavanywa kunye novavanyo.
Isicelo sesampulu yale ngxelo @ https://www.graphicalresearch.com/request/1364/sample
Ubukho bemigaqo efanelekileyo karhulumente kunye nokwanda kolwazi lweemvavanyo ze-coronavirus kukhuthaze iinkampani zokhathalelo lwempilo ukuba zonyuse amandla emveliso yeekiti zovavanyo ze-COVID-19. Kuxelwe ukuba i-Asia Pacific i-COVID-19 ikhithi yokufumana ubungakanani bemakethi kuqikelelwa ukuba ingagqitha kwi-US $ 1.8 yezigidigidi ngo-2026 ngokubhekisele kumvuzo wonyaka. Zikhankanywe ngezantsi zezinye zezinto eziqhuba imeko yentengiso.
Amanyathelo karhulumente okulwa i-COVID-19
Ngokwe-Indian Council of Medical Research (ICMR), iinkampani zezixhobo zonyango zaseIndiya zinokuvelisa kwaye zibonelele ngeekiti zokuqonda isifo kurhulumente nakwiilebhu zabucala emva kokufumana ukwamkelwa kwiNational Institute of Virology (NIV). Iifemu akufuneki zilinde ukuvunywa kwi-Yurophu ye-Yurophu nakwi-US FDA ngaphambi kokuba isasazwe. Iinzame ezifanayo kwiAsia Pacific ukunqanda ukuthintelwa kolawulo kunye nokulwa nokusasazeka kwintsholongwane kuya kudala amathuba ophuhliso kunye nokuthengiswa kweekiti zovavanyo.
Ukonyuka kwemfuno yeekiti zokuvavanywa kwe-RT-PCR
Umzi mveliso we-COVID-19 wovavanyo lwekhithi, ngokweemveliso, wahlulwe ngokweziqwenga zovavanyo lwe-immunoassay kunye neekiti zokuvavanywa kwe-RT-PCR. Indlela yovavanyo ye-RT-PCR iphendula kakhulu kwaye icacile kwindalo enceda ekufumaneni ubukho bentsholongwane ye-SARS-COV-2 kwisampulu yesigulana. Kwelinye icala, indlela esekwe kwi-immunoassay ebonelela ngeziphumo ezikhawulezayo ikwafuna uvavanyo lokuqinisekisa ngeposi kusetyenziswa indlela ye-RT-PCR. Kuxelwe ukuba, i-APAC RT-PCR yokuvavanywa kweekhithi kulindeleke ukuba inyuke phantse ngama-20% e-CAGR kule minyaka izayo.
Ukucaciswa kwe-nasopharyngeal swabs
Umzi-mveliso wekhithi we-COVID-19 ubonwa ngokwahlulwa-hlulwa kwi-nasopharyngeal swab, nasal swab, oropharyngeal swab, kunye nezinye iintlobo zeesampulu. Ngenxa yokucaciswa okuphezulu kunye nokuvunwa okuhle, icandelo le-nasopharyngeal swab liphethe isabelo sentengiso esimalunga ne-45%, xa kuthelekiswa nazo zonke ezinye iintlobo zeesampulu. Ngaphandle kokubamba isabelo esibonakalayo, imiba yokusebenzisa i-nasal swab ibandakanya ukucaciswa okuncinci kunye nesivuno.
Ukukhetha uvavanyo kumaziko ovavanyo
Abasebenzisi bokugqibela be-COVID-19 izixhobo zokubona eAsia Pacific zizibhedlele kunye namaziko oxilongo. Imfuno zeKt kuwo onke amaziko okuxilonga zaxabiswa phantse kwizigidi ezingama-200 zeedola e-US ngo-2020. Oku kungenxa yokuba nokwenzeka kweemvavanyo kula maziko. Ukufumaneka kweengcali ezinezakhono kunye nezixhobo eziphambili kumaziko okuxilonga kwenza ukuba kuvavanywe inani elikhulu leesampulu.
Nangona inezinga lokuphola elimangalisayo phantse le-80% kwesi sifo, i-India ibona inani elinzima lokusweleka ngenxa yokunqongophala kweziseko zononophelo lwempilo. Phantse kuvavanyo lwe-1 yezigidi ngosuku, kunye nenkxaso kurhulumente yokuqalisa okubandakanyekayo kuvavanyo olusebenzayo kunye nolutsha lwe-coronavirus test iya kuqhubela phambili ukufikelela kwiikiti kwilizwe. I-India i-COVID-19 yokufumana ubungakanani beemakethi ubungakanani bemakethi kuqikelelwa ukuba inyuke kwi-CAGR ye-28% ukuya ku-2026.
Iinkampani ezihamba phambili ezibonelela ngeekiti zokufumanisa i-COVID-19 kulo mmandla zibandakanya iShenzhen Bioeasy Biotechnology, Co-Diagnostics, Cepheid, BioFire Diagnostics, Guangzhou Wondfo Biotech, F. Hoffmann-La Roche, Qiagen, Mylab Discovery Solutions, SD Biosensor, Thermo Fisher Scientific, Seegene , Abbott, kunye neBGI.
Bhrawuza ulwazi oluphambili lweshishini kunye ne-TOC epheleleyo @ https://www.graphicalresearch.com/table-of-content/1364/asia-pacific-covid-19-detection-kits-market
Malunga noPhando lweMifanekiso:
Imizobo yoPhando yinkampani yophando enikezela ukuqonda kweshishini, uqikelelo lweemarike kunye negalelo lobuchule ngeengxelo zophando lwegranular kunye neenkonzo zeengcebiso. Sipapasha iingxelo zophando ekujoliswe kuzo ngenjongo zokujongana neemfuno zabathengi ezahlukeneyo, ukusuka ekungeneni kwimakethi nakwizicwangciso zokungena kulawulo lweepotfoliyo kunye nembono yeqhinga. Siyaqonda ukuba iimfuno zeshishini zahlukile: iingxelo zethu zamashishini ziyilelwe ukuqinisekisa ukubaluleka kwabathathi-nxaxheba kushishino kulo lonke ixabiso lexabiso. Sikwabonelela ngeengxelo zesiko ezilungiselelwe iimfuno ngqo zomthengi, ngenkxaso yabahlalutyi abazinikeleyo kulo lonke ixesha lokuthenga.
Qhagamshelana nathi:
UParikhit B.
Ukuthengisa ngokudibeneyo,
Imizobo yoPhando
email: [imeyile ikhuselwe]
web: https://www.graphicalresearch.com
Lo mxholo upapashwe yinkampani yoPhando lweGraphical. ISebe leendaba leWiredRelease alibandakanyekanga ekwenziweni kwalo mxholo. Ngemibuzo malunga nenkonzo yokukhutshwa kweendaba, nceda usifikelele apha [imeyile ikhuselwe].
